Also listed on Therakos Development Limited, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Nov 22, 2027 · High confidence
20-year base term ended Dec 19, 2025
Held by Therakos Holdings USA, LLC
Filed Dec 19, 2005 as application 11/311,714 · Granted Nov 15, 2011
Base term plus 703 days of patent term adjustment (USPTO delay)
Today
2005
2027
Clock starts
Dec 19, 2005
Dec 19, 2005
Term ends
Nov 22, 2027
Nov 22, 2027
Granted
Nov 15, 2011
Nov 15, 2011
base term
patent term adjustment
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
703
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 703 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 19, 2005, when this application, 11/311,714, was filed | Dec 19, 2025 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +703 days, USPTO patent term adjustment record | Nov 22, 2027 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Nov 22, 2027 | High confidence |
This family
| US 8,057,785 | this patent Nov 2027 | Nov 2027 |
| US 8,481,008 | Term ended Dec 2025 | Dec 2025 |
The applications whose file history this site holds. The family may have others.
Assignments
The 40 most recent of 141 recorded documents are shown; the 101 earliest are not. Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Mallinckrodt US Holdings LLC | Release of Patent Security Interests Recorded at Reel 036662, Frame 0053 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Imc Exploration Company | Release of Patent Security Interests Recorded at Reel 036662, Frame 0053 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Meh, Inc. | Release of Patent Security Interests Recorded at Reel 036662, Frame 0053 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Mallinckrodt Hospital Products IP Unlimited Company (F/K/A Mallinckrodt Hospital Products IP Limited) | Release of Patent Security Interests Recorded at Reel 036662, Frame 0053 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Mallinckrodt Ard IP Unlimited Company (F/K/A Mallinckrodt Ard IP Limited) | Release of Patent Security Interests Recorded at Reel 036662, Frame 0053 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Ocera Therapeutics LLC (F/K/A Ocera Therapeutics, Inc.) | Release of Patent Security Interests Recorded at Reel 036662, Frame 0053 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Specgx LLC | Release of Patent Security Interests Recorded at Reel 036662, Frame 0053 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Stratatech Corporation | Release of Patent Security Interests Recorded at Reel 036662, Frame 0053 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Sucampo Pharma Americas LLC | Release of Patent Security Interests Recorded at Reel 036662, Frame 0053 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Vtesse LLC (F/K/A Vtesse Inc.) | Release of Patent Security Interests Recorded at Reel 036662, Frame 0053 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Mallinckrodt Pharmaceuticals Ireland Limited | Release of Patent Security Interests Recorded at Reel 036662, Frame 0053 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Mallinckrodt Pharma IP Trading Unlimited Company (F/K/A Mallinckrodt Pharma IP Trading D.A.C.) | Release of Patent Security Interests Recorded at Reel 036662, Frame 0053 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Infacare Pharmaceutical Corporation | Release of Patent Security Interests Recorded at Reel 036662, Frame 0053 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | ST Shared Services LLC | Release of Patent Security Interests Recorded at Reel 036662, Frame 0053 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Therakos, Inc. | Release of Patent Security Interests Recorded at Reel 036662, Frame 0053 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Ikaria Therapeutics LLC | Release of Patent Security Interests Recorded at Reel 036662, Frame 0053 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Ino Therapeutics LLC | Release of Patent Security Interests Recorded at Reel 036662, Frame 0053 |
| Nov 4, 2024 Reel 69127, frame 749 | Mallinckrodt Hospital Products IP Unlimited Company | Mallinckrodt Pharmaceuticals Ireland Limited | Assignment of Assignor's Interest |
| Nov 4, 2024 Reel 69301, frame 664 | Mallinckrodt Hospital Products IP Limited | Mallinckrodt Hospital Products IP Unlimited Company | Change of Name |
| Dec 3, 2024 Reel 69476, frame 103 | Acquiom Agency Services, LLC, as Collateral Agent | Mallinckrodt Pharma IP Trading Limited; Stratatech Corporation; Mallinckrodt Pharmaceuticals Ireland Limited | Release of Security Interests |
| Dec 3, 2024 Reel 69476, frame 380 | Solaris Ipco Limited | Nomura Corporation Funding Americas, LLC, as Administrative Agent and Collateral Agent | Patent Security Agreement |
| Dec 3, 2024 reel/frame not recorded | Acquiom Agency Services, LLC, as Collateral Agent | Mallinckrodt Pharma IP Trading Limited | Release of Security Interests |
| Dec 3, 2024 reel/frame not recorded | Acquiom Agency Services, LLC, as Collateral Agent | Stratatech Corporation | Release of Security Interests |
| Dec 3, 2024 reel/frame not recorded | Acquiom Agency Services, LLC, as Collateral Agent | Mallinckrodt Pharmaceuticals Ireland Limited | Release of Security Interests |
| Mar 25, 2025 Reel 70623, frame 163 | Mallinckrodt Pharmaceuticals Ireland Limited | Therakos Development Limited | Assignment of Assignor's Interest |
| Aug 14, 2025 Reel 72324, frame 740 | Acquiom Agency Services LLC | Mallinckrodt Enterprises LLC; Mallinckrodt LLC; Mallinckrodt Pharma IP Trading Unlimited Company; Mallinckrodt Pharmaceuticals Ireland Limited; Ocera Therapeutics LLC; Specgx LLC; Stratatech Corporation; Sucampo Pharma Americas LLC; Vtesse LLC | Release of Security Interest |
| Aug 14, 2025 reel/frame not recorded | Acquiom Agency Services LLC | Mallinckrodt Enterprises LLC | Release of Security Interest |
| Aug 14, 2025 reel/frame not recorded | Acquiom Agency Services LLC | Mallinckrodt LLC | Release of Security Interest |
| Aug 14, 2025 reel/frame not recorded | Acquiom Agency Services LLC | Mallinckrodt Pharma IP Trading Unlimited Company | Release of Security Interest |
| Aug 14, 2025 reel/frame not recorded | Acquiom Agency Services LLC | Mallinckrodt Pharmaceuticals Ireland Limited | Release of Security Interest |
| Aug 14, 2025 reel/frame not recorded | Acquiom Agency Services LLC | Ocera Therapeutics LLC | Release of Security Interest |
| Aug 14, 2025 reel/frame not recorded | Acquiom Agency Services LLC | Specgx LLC | Release of Security Interest |
| Aug 14, 2025 reel/frame not recorded | Acquiom Agency Services LLC | Stratatech Corporation | Release of Security Interest |
| Aug 14, 2025 reel/frame not recorded | Acquiom Agency Services LLC | Sucampo Pharma Americas LLC | Release of Security Interest |
| Aug 14, 2025 reel/frame not recorded | Acquiom Agency Services LLC | Vtesse LLC | Release of Security Interest |
| Mar 17, 2026 Reel 75101, frame 970 | Nomura Corporate Funding Americas, LLC, as Administrative Agent and Collateral Agent | Therakos Development Limited | Release of Patent Security Interest Recorded at Reel 69476, Frame 0380 |
| Mar 17, 2026 Reel 75102, frame 334 | Therakos Holdings USA, LLC | Nomura Corporate Funding Americas, LLC, as Administrative Agent and Collateral Agent | Patent Security Agreement |
| Mar 23, 2026 Reel 75227, frame 886 | Therakos Development Limited | Therakos Holdings USA, LLC | Assignment of Assignor's Interest |
| Apr 10, 2026 Reel 75393, frame 921 | Mallinckrodt Hospital Products IP Unlimited Company | Mallinckrodt Pharmaceuticals Ireland Limited Company | Assignment of Assignor's Interest |
| May 22, 2026 Reel 75713, frame 146 | Therakos Development Limited | Therakos Holdings USA, LLC | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Nov 2027
Term ends Nov 22, 2027. No further fees fall due before then
Note
The 703 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
9
later US patents cite this one
That is above the median of utility patents granted in 2011 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.